Difference between revisions of "CERNA1"
| Line 10: | Line 10: | ||
===RefSeq(supplied by NCBI)=== | ===RefSeq(supplied by NCBI)=== | ||
NR_102751 | NR_102751 | ||
| − | |||
| − | |||
===Characteristics=== | ===Characteristics=== | ||
CERNA1 is a 1520bp length validated long noncoding RNA. It locates in chromosome 15 (21.1) and antisense to guanine nucleotide binding protein,beta 5 (GNB5) and myosin VC (MYO5C). <ref name="ref1" /> | CERNA1 is a 1520bp length validated long noncoding RNA. It locates in chromosome 15 (21.1) and antisense to guanine nucleotide binding protein,beta 5 (GNB5) and myosin VC (MYO5C). <ref name="ref1" /> | ||
Revision as of 10:43, 15 October 2017
Contents
Annotated Information
LncRNA CERNA1 was upregulated by ABO.[1]
LncRNA CERNA1 regulated the expression of miR-4707-5p and miR-4767 by directly binding with them.[1]
Approved Symbol
CERNA1 (competing endogenous lncRNA 1 for miR-4707-5p and miR-4767)
Synonyms
LOC100129973
Chromosome
15q21.2
RefSeq(supplied by NCBI)
NR_102751
Characteristics
CERNA1 is a 1520bp length validated long noncoding RNA. It locates in chromosome 15 (21.1) and antisense to guanine nucleotide binding protein,beta 5 (GNB5) and myosin VC (MYO5C). [1] CERNA1 is only found in Homo sapiens.[1]
Expression
CERNA1 wis upregulated by ABO (6-amino-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine) treatment in a dose- and time -dependent manner.
Disease
cardiovascular disease
Function
CERNA1 suppresses apoptosis by targeting miR-4707-5p and miR-4767 in vascular endothelial cells.[1]
Labs working on this lncRNA
- Shandong Provincial Key Laboratory of Animal Cells and Developmental Biology, School of Life Science, Shandong University, Jinan 250100, China.
- Institute of Organic Chemistry, School of Chemistry and Chemical Engineering, Shandong University, Jinan 250100, China.
- The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Health, Shandong University Qilu Hospital, Jinan, 250012, China.
